Skip to the main content

Original scientific paper

Evaluation of the Rodent Hershberger Bioassay Using Three Reference (Anti)Androgens

Alexius Freyberger
Elke Hartmann
Franc Krötlinger


Full text: english pdf 104 Kb

page 131-139

downloads: 833

cite


Abstract

Under the umbrella of the Organization for Economic Cooperation and Development (OECD) the rodent Hershberger bioassay is being validated as an in vivo screen for the detection of (anti)androgens. As part of the validation work we studied trenbolone (TREN), 1,1-bis-(4-chlorophenyl)-2,2-dichloroethylene (p,p'-DDE) and vinclozolin (VIN). Oral intubation of castrated rats with TREN [0.3-1.5-8-40 mg kg-1 body weight (b.w.)] for ten days increased androgen-sensitive tissue weights (ASTW) at the high dose. p,p'-DDE (5-16-50-160 mg kg-1 b.w.) and VIN (0-3-10-30-100 mg kg-1 b.w.) orally administered for ten days produced a dose-dependent decrease in ASTW in castrated rats subcutaneously supplemented with testosterone propionate (0.4 mg kg-1 b.w.). p,p'-DDE also strongly increased liver weights and induced hepatocellular hypertrophy and thyroid follicular cell hypertrophy that was most likely mediated by liver enzyme induction. Our data strongly suggest that the OECD protocol of the rodent Hershberger bioassay describes a sensitive in vivo screen, capable of detecting weakly active (anti)androgens. Furthermore, our data may also indicate that thyroid effects could be assessed, if the protocol is amended accordingly.

Keywords

in vivo screen, OECD, p,p'-DDE, thyroid, trenbolone, vinclozolin

Hrčak ID:

141

URI

https://hrcak.srce.hr/141

Article data in other languages: croatian

Visits: 1.404 *